77.35 USD
▲+0.52+4.84%
盘后 73.78 0.00%
2026-08-03
市值
$762.47M
市盈率
—
EPS
-2.48
股息率
—
52 周区间
32.50 – 123.75
成交量
167.42K
Beta
0.10
目标价
166.62
52W 低 32.5052W 高 123.75
价格走势
公司简介
Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes 5-HT2 Receptors, which are serotonin agonists for epilepsy and neuropsychiatric disorders; and BMB-101, which has completed phase 1 trial for undisclosed seizure disorder and is in phase 2 clinical trials for the developmental and epileptic encephalopathies and absence epilepsies. The company also develops BMB-201 and BMB-202 for the treatment of neurop...